Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03814005
Title A Study of Pevonedistat in Combination With Azacitidine in Participants With Higher-risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myelogenous Leukemia (AML) With Severe Renal Impairment or Mild Hepatic Impairment
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27514 United States Details
ICO lHospitalet Hospital Duran i Reynals LHospitalet de Llobregat Barcelona 8908 Spain Details
Hospital Universitario Vall d'Hebron - PPDS Barcelona 8035 Spain Details
Hospital de San Pedro de Alcantara Caceres 10003 Spain Details
C.H. Regional Reina Sofia Cordoba 14004 Spain Details
Complejo Asistencial Universitario de Salamanca H. Clinico Salamanca 37007 Spain Details
Hospital Universitario Virgen del Rocio - PPDS Sevilla 41013 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field